These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23989616)

  • 1. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer.
    Lisanti MP; Sotgia F; Pestell RG; Howell A; Martinez-Outschoorn UE
    Cell Cycle; 2013 Sep; 12(18):2935-6. PubMed ID: 23989616
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
    Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F
    Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
    Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast.
    Zhai Y; Chai L; Chen J
    Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):263-272. PubMed ID: 28625953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.
    Martinez-Outschoorn UE; Balliet R; Lin Z; Whitaker-Menezes D; Birbe RC; Bombonati A; Pavlides S; Lamb R; Sneddon S; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Dec; 11(23):4402-13. PubMed ID: 23172369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention.
    Sanchez-Alvarez R; Martinez-Outschoorn UE; Lin Z; Lamb R; Hulit J; Howell A; Sotgia F; Rubin E; Lisanti MP
    Cell Cycle; 2013 Jan; 12(2):289-301. PubMed ID: 23257780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.
    Monti D; Sotgia F; Whitaker-Menezes D; Tuluc M; Birbe R; Berger A; Lazar M; Cotzia P; Draganova-Tacheva R; Lin Z; Domingo-Vidal M; Newberg A; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):226-232. PubMed ID: 29248134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma.
    Jiang E; Xu Z; Wang M; Yan T; Huang C; Zhou X; Liu Q; Wang L; Chen Y; Wang H; Liu K; Shao Z; Shang Z
    FASEB J; 2019 Apr; 33(4):5690-5703. PubMed ID: 30698991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
    Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
    J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors.
    Zhao Z; Han F; He Y; Yang S; Hua L; Wu J; Zhan W
    Eur J Surg Oncol; 2014 Oct; 40(10):1361-8. PubMed ID: 24821064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma.
    Domingo-Vidal M; Whitaker-Menezes D; Martos-Rus C; Tassone P; Snyder CM; Tuluc M; Philp N; Curry J; Martinez-Outschoorn U
    Mol Cancer Res; 2019 Sep; 17(9):1893-1909. PubMed ID: 31239287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device.
    Shi H; Jiang H; Wang L; Cao Y; Liu P; Xu X; Wang Y; Sun L; Niu H
    Cell Cycle; 2015; 14(19):3058-65. PubMed ID: 26125467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.
    Gallagher SM; Castorino JJ; Wang D; Philp NJ
    Cancer Res; 2007 May; 67(9):4182-9. PubMed ID: 17483329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.
    Gotanda Y; Akagi Y; Kawahara A; Kinugasa T; Yoshida T; Ryu Y; Shiratsuchi I; Kage M; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2941-7. PubMed ID: 23780984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells.
    Hu X; Liu Z; Duan X; Han X; Yuan M; Liu L; Xia X; Li N; Qin J; Wang Y
    Mol Carcinog; 2021 Oct; 60(10):702-714. PubMed ID: 34347919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.